Skip to main content
Therma Bright Inc. logo

Therma Bright Inc. — Investor Relations & Filings

Ticker · THRM ISIN · CA8834262070 LEI · 529900PN7P0GSORO2174 TSXV Manufacturing
Filings indexed 525 across all filing types
Latest filing 2026-01-20 Regulatory Filings
Country CA Canada
Listing TSXV THRM

About Therma Bright Inc.

https://www.thermabright.com/

Therma Bright Inc. is a medical technology company that develops, acquires, and markets proprietary diagnostic and medical device technologies for the consumer and institutional healthcare sectors. The company's portfolio addresses key areas including pain management, circulation, diagnostics, and critical care. Core products and development projects include Venowave, a medical device designed to boost circulation and prevent blood clots; the Digital Cough Test (DCT), an AI-powered application developed with AI4LYF for rapid, non-invasive detection of respiratory diseases; and the PREVA™ clot retriever, developed with Inretio for enhanced thrombectomy procedures in ischemic stroke treatment. Furthermore, Therma Bright is advancing inhaled statin therapy in partnership with InVixa for the treatment of COVID-19 pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2026-01-20 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2025-12-22 English
Interim MD&A - English.pdf
Regulatory Filings
2025-12-22 English
Interim financial statements/report – English.pdf
Regulatory Filings
2025-12-22 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a 'Material Change Report' (Form 51-102F3) filed by Therma Bright Inc. in accordance with Canadian securities regulations. It explicitly references a news release regarding the progress of an investee company, InStatin. While it contains a news release, the primary document is a formal regulatory filing used to report material changes to the market. Since it does not fit into specific categories like 10-K or IR, and serves as a formal regulatory disclosure of a material event, it is classified as a Regulatory Filing (RNS).
2025-12-19 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release issued by Therma Bright Inc. regarding the operational and clinical progress of its investee company, InStatin. It details strategic updates, clinical developments, team growth, and future fundraising plans. As it is a general corporate announcement regarding business activities and does not fit into specific categories like financial reports, board changes, or dividend notices, it is classified as a general regulatory filing/press release.
2025-12-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.